Technology that protects bacteria-based oral vaccines from destruction by the digestive system

18 June 2013 / By Tim / Featured Videos, Featured on App, Prophylactic Vaccines, R&D / 0 comments

“A new technology is being developed by the University of Cambridge to protect bacteria-based oral vaccines from destruction by the digestive system, to enable their [...]

More in R&D

Medicago “first in the world” to report positive pre-clinical data for H7N9 vaccine

11 June 2013 / By Tim / Featured on App, Flu, Prophylactic Vaccines, R&D / 2 comments
TeloVac Phase III cancer vaccine trial disappoints, but not without silver linings

5 June 2013 / By Tim / Featured on App, R&D, Therapeutic Vaccines / 1 comment
Download presentation: Challenges to Using Adjuvants

4 June 2013 / By Freya Smale / Featured on App, R&D / 0 comments
Sinovac files new drug application for hand, foot and mouth EV71 vaccine

3 June 2013 / By Tim / Emerging Markets, Featured on App, R&D, Regulation and Policy / 0 comments
Anthrax vaccine showdown as PharmAthene’s SparVax Phase II gets FDA go ahead

31 May 2013 / By Tim / Featured on App, Prophylactic Vaccines, R&D, Therapeutic Vaccines / 0 comments
GSK buys Okairos for $324 million in vaccine boost effort

29 May 2013 / By Tim / Featured on App, Partnering and Corporate strategy, Prophylactic Vaccines, R&D / 0 comments
Dispute erupts over novel coronavirus patent claims

29 May 2013 / By Tim / Featured on App, Prophylactic Vaccines, R&D, Regulation and Policy / 0 comments
New vaccine developed for Hand, Foot and Mouth Disease in China

29 May 2013 / By Tim / Emerging Markets, Featured on App, Prophylactic Vaccines, R&D / 0 comments
Vaccines for the future – Dr. Rino Rappuoli, Head of R&D, Novartis Vaccines

28 May 2013 / By Tim / Featured Videos, Featured on App, R&D / 0 comments
Hunt for broad-spectrum vaccine: PNAG on more microbes than previously thought

28 May 2013 / By Tim / Featured on App, R&D, Therapeutic Vaccines / 0 comments